NeuExcell, Spark Therapeutics To Collaborate To Develop Novel Gene Therapy For Huntington's Disease

NeuExcell Therapeutics announced that it has agreed gene therapy collaboration with Spark Therapeutics, a member of the Roche Group (RHHBY) to develop an effective and safe treatment for patients suffering from Huntington's Disease or HD.

Under deal, Spark Therapeutics has the option to license the exclusive worldwide rights of the NeuExcell's HD program. Under the Option, NeuExcell said it is eligible to receive upfront, license fees, R&D and Sales milestone payments up to about $190 million plus product royalties.

Under terms, Spark Therapeutics will get access to NeuExcell's proprietary neuro-regenerative gene therapy platform and capabilities. NeuExcell's research team will collaborate closely with Spark Therapeutics to advance the program.

"We are looking forward to our collaboration with NeuExcell and to explore their unique neuroregenerative gene therapy platform," said Federico Mingozzi, Ph.D., Chief Scientific Officer of Spark Therapeutics.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Royal Caribbean Group's ultra-luxury brand Silversea Cruises is set to launch the world's first hybrid-powered cruise ship in the summer of 2023. This will also be the first ship with large-scale fuel cell technology to enable emission-free port operations. The fuel cells will provide 100% of power while at port. Affco USA is recalling around 24,461 pounds of frozen raw lamb shoulder products that were not presented for import re-inspection into the U.S., the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced. The recall involves the frozen raw lamb shoulder items that were imported on July 12, 2021. American Express Company (AXP) reported an increase in profit for the third quarter that also topped Wall Street estimates. Consolidated total revenues net of interest expense rose 25 percent year-on-year, primarily reflecting growth in Card Member spending, as well as a rise in the average discount...
Follow RTT